Singapore markets open in 3 hours 51 minutes

AIM ImmunoTech Inc. (AIM)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.4251+0.0001 (+0.02%)
At close: 04:00PM EDT
0.4354 +0.01 (+2.42%)
After hours: 05:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 21.57M
Enterprise value 9.91M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)102.22
Price/book (mrq)2.26
Enterprise value/revenue 49.04
Enterprise value/EBITDA -0.31

Trading information

Stock price history

Beta (5Y monthly) -0.15
52-week change 3-8.51%
S&P500 52-week change 325.38%
52-week high 30.7500
52-week low 30.3200
50-day moving average 30.4328
200-day moving average 30.4854

Share statistics

Avg vol (3-month) 3228.54k
Avg vol (10-day) 3166.39k
Shares outstanding 550.75M
Implied shares outstanding 650.75M
Float 845.42M
% held by insiders 18.81%
% held by institutions 18.09%
Shares short (15 Apr 2024) 4477.18k
Short ratio (15 Apr 2024) 41.23
Short % of float (15 Apr 2024) 40.96%
Short % of shares outstanding (15 Apr 2024) 40.94%
Shares short (prior month 15 Mar 2024) 4427.05k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 311 Jun 2019
Ex-dividend date 4N/A
Last split factor 21:44
Last split date 311 Jun 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-21,544.62%

Management effectiveness

Return on assets (ttm)-66.64%
Return on equity (ttm)-118.94%

Income statement

Revenue (ttm)202k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)16.10%
Gross profit (ttm)N/A
EBITDA -31.68M
Net income avi to common (ttm)-28.96M
Diluted EPS (ttm)-0.6000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.07M
Total cash per share (mrq)0.26
Total debt (mrq)718k
Total debt/equity (mrq)7.02%
Current ratio (mrq)1.68
Book value per share (mrq)0.19

Cash flow statement

Operating cash flow (ttm)-21.27M
Levered free cash flow (ttm)-12.16M